Preparing for future pandemics
CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.
Find out more
Latest News
Latest News
COVAX: The “world first” vaccine sharing scheme that saved millions
Former head of COVAX, Aurélia Nguyen, shares her reflections on the achievements of this pioneering vaccine-sharing scheme.
CEPI appoints Executive Director of People and Organisation
Claire Hoang Sperandio will join CEPI in September.
Pandemic speed: How rapid-response science saves lives
Life-saving responses mean speed, scale and access
Pioneering research to develop all-in-one vaccine against some of the world’s most deadly diseases
Scientists at Denmark’s Adaptvac will lead the development of a new vaccine that could provide all-in-one protection against multiple deadly viruses including Ebolavirus Zaire, Sudan Ebolavirus and Marburg, all of which cause frequent unpredictable outbreaks in regions of Africa, with significant health and societal impacts and fatality rates of up to 90%.
Rethinking regulation to face future pandemic threats
Regulatory preparedness underscores the 100 Days Mission. Find out how.
Responsibly unleashing artificial intelligence in pandemic preparedness
Meeting innovation with responsibility
Preparedness in practice: Rwanda’s record-breaking Marburg response
Practicing 100 Days Mission preparedness in Rwanda and beyond
CEPI signs new collaborative agreement with US Dept of Defense to expand protection against disease outbreaks
Agreement will enable organisations to collaborate on projects that expand global defences against disease outbreaks.
Public health expert Dr. Kesete Admasu joins CEPI Board
He brings over twenty years of experience working across public health, infectious disease initiatives and philanthropic investment.
.webp){kind=logo}
CEPI statement on the adoption of the Pandemic Agreement
CEPI welcomes the adoption of the Pandemic Agreement
Latest News
We want to create a world in which epidemics and pandemics are no longer a threat to humanity.
CEPI is working to galvanise the development of new vaccines and other biologic countermeasures against diseases that could cause the next devastating epidemic or pandemic.
Our approach
Research and development
CEPI is leading a broad range of ambitious programmes that aim to substantially reduce global epidemic and pandemic risk.
Calls for Proposals
Innovators worldwide are invited to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.
Manufacturing and supply chain
CEPI is bolstering global manufacturing capacity in underserved regions and harnessing innovative technologies to improve the speed, scale and access of vaccine manufacturing in response to epidemic and pandemic threats.
The Viral Most Wanted
Join CEPI’s disease detectives as they investigate the viral families that have threatened human life for centuries.
$12.5 trillion
IMF’s estimate cost of the COVID-19 pandemic to the global economy through 2024
60+
Number of CEPI-supported vaccine candidates or platform technologies.
$2.8 billion
The minimum average cost to progress one vaccine each against 11 WHO priority infectious diseases
Emerging infectious diseases affect us all. They do not respect borders.
A commitment to equitable access informs every aspect of our work. It is core to CEPI’s vision of a world in which epidemics and pandemics are no longer a threat to humanity.
CEPI take a systems approach to equitable access, seeking to enable equitable access within a broad ecosystem of national and international public and private sector partners and networks.
We work towards this goal by enabling equitable access directly through financial investments and partnerships, and indirectly through advocacy and policy contributions to the evolving ecosystem.
Where to go next
